HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 279, Issue 10, 9557-9564, March 5, 2004

This Article Full Text Full Text (PDF) All Versions of this Article: 279/10/9557    most recent M310512200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Beigneux, A. P. Articles by Young, S. G. Search for Related Content PubMed PubMed Citation Articles by Beigneux, A. P. Articles by Young, S. G. Social Bookmarking                      What's this?

ATP-Citrate Lyase Deficiency in the Mouse^*

Anne P. Beigneux¶, Cynthia Kosinski, Bryant Gavino, Jay D. Horton||**, William C. Skarnes, and Stephen G. Young

From the Gladstone Institute of Cardiovascular Disease and the Cardiovascular Research Institute, University of California, San Francisco, California 94141-9100, the Departments of ^||Molecular Genetics and ^**Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9046, the Department of Medicine, University of California, San Francisco, California 94141-9100, and the Department of Molecular and Cell Biology, University of California, Berkeley, California 94720

ATP-citrate lyase (Acly) is one of two cytosolic enzymes that synthesize acetyl-coenzyme A (CoA). Because acetyl-CoA is an essential building block for cholesterol and triglycerides, Acly has been considered a therapeutic target for hyperlipidemias and obesity. To define the phenotype of Acly-deficient mice, we created Acly knockout mice in which a -galactosidase marker is expressed from Acly regulatory sequences. We also sought to define the cell type-specific expression patterns of Acly to further elucidate the in vivo roles of the enzyme. Homozygous Acly knockout mice died early in development. Heterozygous mice were healthy, fertile, and normolipidemic on both chow and high fat diets, despite expressing half-normal amounts of Acly mRNA and protein. Fibroblasts and hepatocytes from heterozygous Acly mice contained half-normal amounts of Acly mRNA and protein, but this did not perturb triglyceride and cholesterol synthesis or the expression of lipid biosynthetic genes regulated by sterol regulatory element-binding proteins. The expression of acetyl-CoA synthetase 1, another cytosolic enzyme for producing acetyl-CoA, was not up-regulated. As judged by -galactosidase staining, Acly was expressed ubiquitously but was expressed particularly highly in tissues with high levels of lipogenesis, such as in the livers of mice fed a high-carbohydrate diet. -Galactosidase staining was intense in the developing brain, in keeping with the high levels of de novo lipogenesis of the tissue. In the adult brain, -galactosidase staining was in general much lower, consistent with reduced levels of lipogenesis; however, -galactosidase expression remained very high in cholinergic neurons, likely reflecting the importance of Acly in generating acetyl-CoA for acetylcholine synthesis. The Acly knockout allele is useful for identifying cell types with a high demand for acetyl-CoA synthesis.

Received for publication, September 23, 2003 , and in revised form, December 5, 2003.

^* This work was supported by National Institutes of Health NHLBI Program in Genomics Applications Grants "BayGenomics" HL66621, HL66600, and HL66590. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

^¶ To whom correspondence should be addressed: Gladstone Institute of Cardiovascular Disease, P. O. Box 419100, San Francisco, CA 94141-9100. Tel.: 415-826-7500; Fax: 415-285-5632; E-mail: abeigneux{at}gladstone.ucsf.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. J. Wakil and L. A. Abu-Elheiga Fatty acid metabolism: target for metabolic syndrome J. Lipid Res., April 1, 2009; 50(Supplement): S138 - S143. [Abstract] [Full Text] [PDF]

				N. Zidek, J. Hellmann, P.-J. Kramer, and P. G. Hewitt Acute Hepatotoxicity: A Predictive Model Based on Focused Illumina Microarrays Toxicol. Sci., September 1, 2007; 99(1): 289 - 302. [Abstract] [Full Text] [PDF]

				S. Bhusari, Z. Liu, L. B. Hearne, D. E. Spiers, W. R. Lamberson, and E. Antoniou Expression Profiling of Heat Stress Effects on Mice Fed Ergot Alkaloids Toxicol. Sci., January 1, 2007; 95(1): 89 - 97. [Abstract] [Full Text] [PDF]

				K. Reue and L. Vergnes Thematic review series: Systems Biology Approaches to Metabolic and Cardiovascular Disorders. Approaches to lipid metabolism gene identification and characterization in the postgenomic era J. Lipid Res., September 1, 2006; 47(9): 1891 - 1907. [Abstract] [Full Text] [PDF]

				Y. Sun, K. Boyd, W. Xu, J. Ma, C. W. Jackson, A. Fu, J. M. Shillingford, G. W. Robinson, L. Hennighausen, J. K. Hitzler, et al. Acute Myeloid Leukemia-Associated Mkl1 (Mrtf-a) Is a Key Regulator of Mammary Gland Function Mol. Cell. Biol., August 1, 2006; 26(15): 5809 - 5826. [Abstract] [Full Text] [PDF]

				L. Vergnes, A. P. Beigneux, R. Davis, S. M. Watkins, S. G. Young, and K. Reue Agpat6 deficiency causes subdermal lipodystrophy and resistance to obesity J. Lipid Res., April 1, 2006; 47(4): 745 - 754. [Abstract] [Full Text] [PDF]

				A. P. Beigneux, L. Vergnes, X. Qiao, S. Quatela, R. Davis, S. M. Watkins, R. A. Coleman, R. L. Walzem, M. Philips, K. Reue, et al. Agpat6--a novel lipid biosynthetic gene required for triacylglycerol production in mammary epithelium J. Lipid Res., April 1, 2006; 47(4): 734 - 744. [Abstract] [Full Text] [PDF]

				E. P. Brandon, T. Mellott, D. P. Pizzo, N. Coufal, K. A. D'Amour, K. Gobeske, M. Lortie, I. Lopez-Coviella, B. Berse, L. J. Thal, et al. Choline Transporter 1 Maintains Cholinergic Function in Choline Acetyltransferase Haploinsufficiency J. Neurosci., June 16, 2004; 24(24): 5459 - 5466. [Abstract] [Full Text] [PDF]